Diabetic macular edema (DME) is a complication of diabetes that occurs when fluid builds up in the macula, the part of the retina responsible for central vision. This can lead to blurred or double ...

Blood glucose levels in patients with diabetes are strongly correlated with the risk for cystoid macular edema and thickening ...

Sickle cell disease and sickle cell trait can increase the risk of eye diseases associated with diabetes mellitus, a study ...

Diabetic macular edema (DME) is a leading cause of vision loss in people with diabetes. It occurs when high blood sugar levels damage small blood vessels in the retina, the light-sensitive tissue ...

A single intravitreal injection of UBX1325 (foselutoclax) was shown to be safe in patients with diabetic macular edema ... more Early Treatment of Diabetic Retinopathy Study (ETDRS) letters ...

Ashvattha Therapeutics reveals promising phase 2 results for migaldendranib, showcasing significant improvements in retinal ...

Phase II trial results indicated that treatment with the firm's antisense oligonucleotide led to stable or improved best-corrected visual acuity.

4D Molecular Therapeutics (FDMT), Thursday announced that the FDA has granted Regenerative Medicine Advanced Therapy designation to its gene therapy candidate 4D-150 for diabetic macular edema.

diabetic macular edema and diabetic retinopathy—and now has the potential to substantially reduce the treatment burden for patients with retinal vein occlusion. We look forward to sharing these ...

In this Healio Video Perspective from the Retina World Congress, Baruch D. Kuppermann, MD, PhD, shares positive data on the dexamethasone intravitreal implant for diabetic macular edema.